Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | -0.03% | 358.42 | 1.2% | $822.65m | |
| AMGN | Amgen Inc. | -0.43% | 191.97 | 1.2% | $549.69m | |
| CELG | Celgene Corporation | -0.11% | 85.69 | 1.2% | $541.75m | |
| GILD | Gilead Sciences, Inc. | 0.68% | 77.64 | 0.9% | $485.98m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.62% | 134.51 | 16.6% | $345.10m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.23% | 180.72 | 1.9% | $321.35m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.12% | 366.42 | 2.6% | $293.85m | |
| ILMN | Illumina, Inc. | 0.79% | 309.72 | 3.5% | $269.35m | |
| BLUE | Bluebird Bio, Inc. | 0.06% | 179.65 | 15.7% | $208.27m | |
| NKTR | Nektar Therapeutics | 1.82% | 48.75 | 5.6% | $178.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.37% | 135.15 | 2.0% | $175.76m | |
| FMI | Foundation Medicine, Inc. | 0.09% | 136.93 | 8.8% | $160.93m | |
| EXAS | Exact Sciences Corporation | 0.81% | 67.28 | 25.4% | $160.59m | |
| EXEL | Exelixis, Inc. | 0.05% | 21.34 | 6.4% | $135.83m | |
| A | Agilent Technologies, Inc. | 2.03% | 64.27 | 1.5% | $132.91m |
Company Profile
Foundation Medicine, Inc. is a molecular information company, which engages in the provision of information on clinical treatment decisions for patients with cancer. Its products includes: FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers; FoundationACT; and FoundationFocus CDxBRCA. The company was founded by Alexis Borisy in November 2009 and is headquartered in Cambridge, MA.